MK-4482 shows potential to prevent and treat SARS-CoV-2 infection.
This scanning electron microscope image shows SARS-CoV-2 (orange) also known as 2019-nCoV, the virus that causes COVID-19 isolated from a patient in the U.S., emerging from the surface of cells (gray) cultured in the lab. NIAID
What
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists. SARS-CoV-2 is the virus that causes COVID-19. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings.
Drug launched at Emory reduces virus that causes COVID-19 to undetectable levels emory.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from emory.edu Daily Mail and Mail on Sunday newspapers.
Our weekly selection of links across the web.
Scot McKnight Image: Photo by Preslie Hirsch on Unsplash
Advent is a time of hope and joy – anticipation, expectation, and aching for God’s redemption. Today’s links express the spirit of Advent’s hope and joy.
BRAINERD, Minn. (NEXSTAR) – One customer’s decision to pay it forward at a Minnesota drive-thru led to a heartwarming show of kindness spanning multiple days and involving over 900 strangers.
It all started with a Dairy Queen customer’s giving spirit in Brainerd, a small city located roughly 100 miles north of Minneapolis….
In response to the news coverage, the restaurant posted this heartfelt message Wednesday: